Lv1
10 积分 2023-12-07 加入
Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma
7小时前
待确认
Evaluation of the oral corticosteroid-sparing effect of tezepelumab in adults with oral corticosteroid-dependent asthma (SOURCE): a randomised, placebo-controlled, phase 3 study
7小时前
已完结
Dupilumab efficacy in relation to changes in club cell secretory protein 16
11小时前
已完结
Oral corticosteroid sparing with omalizumab in severe allergic (IgE-mediated) asthma patients
4天前
已完结
Coronary collaterals by transthoracic echocardiography in coronary artery disease
12天前
已完结
Long-term safety of tezepelumab in patients with asthma: a systematic review and meta-analysis of randomized controlled trials
13天前
已完结
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial
19天前
已完结
Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies
19天前
已完结
The association between blood eosinophil count and benralizumab efficacy for patients with severe, uncontrolled asthma: subanalyses of the Phase III SIROCCO and CALIMA studies
19天前
已完结
Severe Asthma Standard-of-Care Background Medication Reduction With Benralizumab: ANDHI in Practice Substudy
19天前
已关闭
皖公网安备34019202002308
